Search

Search Constraints

You searched for: Author/Creator Sionis, Alessandro

Search Results

13. Circulating levels of microRNA 423‐5p are associated with 90 day mortality in cardiogenic shock. (24th November 2018)

14. Clinical picture and risk prediction of short‐term mortality in cardiogenic shock. (28th March 2015)

15. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome. Issue 7 (July 2017)

16. Comprehensive in‐hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). (30th April 2018)

17. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Issue 1 (December 2016)

18. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Issue 1 (December 2016)

19. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Issue 1 (December 2016)

20. Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study. (December 2020)